GlassScriptPhysician profile
Parin Patel
NPI 1053737643
$8,871.45
in general payments reported to CMS, 2019-2025
38 companies · $4,940 in 2025
The $4,940 reported for 2025 was more than what 90% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.98 · 2020: $116 · 2021: $819 · 2022: $715 · 2023: $950 · 2024: $1,279 · 2025: $4,940.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,645 · Consulting Fee: $3,431 · Travel and Lodging: $93.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,645.29 |
| Consulting Fee | $3,430.55 |
| Travel and Lodging | $93.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,430.55 | 2025 | Tacticath Ablation Catheter, Sensor Enabled |
| Janssen Biotech, INC. | $1,347.85 | 2021-2025 | Erleada, Carvykti, Rybrevant |
| Endo Pharmaceuticals INC. | $403.91 | 2019-2024 | Xiaflex, Aveed, Edex |
| Ferring Pharmaceuticals INC. | $309.74 | 2024-2025 | Adstiladrin |
| Sumitomo Pharma America, INC. | $289.68 | 2023-2025 | Orgovyx, Gemtesa |
| Abbvie INC. | $286.11 | 2020-2025 | |
| Boston Scientific Corporation | $278.71 | 2020-2025 | Farapulse, Spaceoar Vue System - 10ml, Lithovue |
| Pfizer INC. | $263.99 | 2019-2025 | |
| Astellas Pharma US INC | $243.68 | 2021-2024 | Myrbetriq, Xtandi, Veozah |
| Merck Sharp & Dohme LLC | $190.38 | 2021-2024 | Lynparza, Keytruda |
| Bayer Healthcare Pharmaceuticals INC. | $166.64 | 2021-2025 | |
| Teleflex LLC | $158.67 | 2021-2025 | Urolift |
| Becton, Dickinson and Company | $150.09 | 2024 | Bard Urinary Drainage Bag |
| Endo USA, INC. | $144.03 | 2024-2025 | Xiaflex, Aveed, Edex |
| Recor Medical INC | $143.29 | 2025 | Paradise Ultrasound Renal Denervation System |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $135.24 | 2023-2025 | Itind System, Soltive |
| Coloplast Corp | $125.61 | 2021-2024 | Speedicath, Luja Coude |
| Janssen Research & Development, LLC | $93.30 | 2023 | |
| Progenics Pharmaceuticals, INC. | $86.82 | 2022-2025 | Pylarify |
| Urogen Pharma, INC. | $69.77 | 2023-2024 | Jelmyto |
| Dendreon Pharmaceuticals LLC | $67.54 | 2024 | Provenge |
| Myriad Genetic Laboratories, INC. | $60.02 | 2024-2025 | Prolaris, Myrisk |
| Urovant Sciences INC | $59.99 | 2021-2022 | |
| Tolmar, INC. | $58.93 | 2023-2024 | |
| Procept Biorobotics Corporation | $43.09 | 2022-2024 | Aquabeam System |
| Astrazeneca Pharmaceuticals LP | $35.60 | 2020-2022 | |
| Immunitybio, INC. | $30.74 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $30.64 | 2021 | |
| Convatec INC. | $26.02 | 2021 | |
| Calyxo, INC. | $24.33 | 2025 | Cvac Aspiration System |
| Palette Life Sciences, INC. | $19.51 | 2022 | |
| Abc Home Medical Supply, INC. | $18.86 | 2025 | |
| Koelis INC. | $18.46 | 2024 | |
| Accord Healthcare, INC. | $17.38 | 2025 | |
| Blue Earth Diagnostics | $16.71 | 2021 | |
| Axonics, INC. | $14.46 | 2024 | Axonics |
| 180 Medical, INC. | $11.11 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parin Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.